Dysregulation of this selectivity underlies disease pathogenesis: impaired PINK1-Parkin signaling exacerbates mtDAMPs release in COPD, while excessive BNIP3 activation drives fibrosis via unresolved oxidative stress. Here, PRKN is linked to chronic obstructive pulmonary disease.